Therapeutic Asset Ratings

159 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Alpha Tocopherol Radiation Induced Lung Injury (RILI)	University Health Network, Toronto	P2	CCC (53)
Anakinra Early Stage Triple Negative ER Low Breast Cancer	University Health Network, Toronto	P2	CCC (53)
Bms-907351 Liver Transplant	University Health Network, Toronto	P2	CCC (53)
Brigatinib Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Brigatinib Pancreatic Ductal Carcinoma	University Health Network, Toronto	P2	CCC (53)
Capecitabine Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Cediranib Leiomyosarcoma	University Health Network, Toronto	P2	CCC (53)
Ceritinib Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Ceritinib Pancreatic Ductal Carcinoma	University Health Network, Toronto	P2	CCC (53)
Cobimetinib Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
COLCHICINUM Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
COLCHICINUM Pancreatic Ductal Carcinoma	University Health Network, Toronto	P2	CCC (53)
Dostarlimab High Grade Endometrioid Cancer	University Health Network, Toronto	P2	CCC (53)
Dostarlimab High Grade Serous Cancer	University Health Network, Toronto	P2	CCC (53)
Dpx-Survivac Primary Peritoneal Carcinoma	University Health Network, Toronto	P2	CCC (53)
Durvalumab IDH Mutation	University Health Network, Toronto	P2	CCC (53)
Durvalumab Leiomyosarcoma	University Health Network, Toronto	P2	CCC (53)
ETOPOSIDE Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Evofosfamide Castration Resistant Prostate Cancer	University Health Network, Toronto	P2	CCC (53)
Inno-206 Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Irinotecan High Grade Serous Cancer	University Health Network, Toronto	P2	CCC (53)
Marijuana Anxiety	University Health Network, Toronto	P2	CCC (53)
Neratinib Epithelial Tumor	University Health Network, Toronto	P2	CCC (53)
Neratinib Pancreatic Ductal Carcinoma	University Health Network, Toronto	P2	CCC (53)
Niraparib High Grade Endometrioid Cancer	University Health Network, Toronto	P2	CCC (53)

Showing 51 to 75 of 159 assets

PreviousPage 3 of 7Next